These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1093 related articles for article (PubMed ID: 20006859)

  • 41. Magnetic resonance imaging/transrectal ultrasound fusion-targeted prostate biopsy using three-dimensional ultrasound-based organ-tracking technology: Initial experience in Japan.
    Yamada Y; Fujihara A; Shiraishi T; Ueda T; Yamada T; Ueno A; Inoue Y; Kaneko M; Kamoi K; Hongo F; Okihara K; Ukimura O
    Int J Urol; 2019 May; 26(5):544-549. PubMed ID: 30793385
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Targeted MRI-guided prostate biopsies for the detection of prostate cancer: initial clinical experience with real-time 3-dimensional transrectal ultrasound guidance and magnetic resonance/transrectal ultrasound image fusion.
    Fiard G; Hohn N; Descotes JL; Rambeaud JJ; Troccaz J; Long JA
    Urology; 2013 Jun; 81(6):1372-8. PubMed ID: 23540865
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Magnetic resonance imaging-targeted vs. conventional transrectal ultrasound-guided prostate biopsy: single-institution, matched cohort comparison.
    Kim EH; Vemana G; Johnson MH; Vetter JM; Rensing AJ; Strother MC; Fowler KJ; Andriole GL
    Urol Oncol; 2015 Mar; 33(3):109.e1-6. PubMed ID: 25655682
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Usefulness of comparing of magnetic resonance imaging (MRI) findings prior to repeat biopsy and negative initial biopsy as a decision-making method for repeat prostate biopsy].
    Sawazaki H; Sengiku A; Imamura M; Takahashi T; Ogura K; Kobayashi H
    Hinyokika Kiyo; 2014 Apr; 60(4):165-70. PubMed ID: 24882227
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Value of Endorectal Magnetic Resonance Imaging of the Prostate in Improving the Detection of Anterior Prostate Cancer.
    Zugor V; Kühn R; Engelhard K; Poth S; Bernat MM; Porres D; Labanaris AP
    Anticancer Res; 2016 Aug; 36(8):4279-83. PubMed ID: 27466544
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Morphologic, functional, and metabolic magnetic resonance imaging-guided prostate biopsy in a patient with prior negative transrectal ultrasound-guided biopsies and persistently elevated prostate-specific antigen levels.
    Lichy MP; Anastasiadis AG; Aschoff P; Sotlar K; Eschmann SM; Pfannenberg C; Stenzl A; Claussen CD; Schlemmer HP
    Urology; 2007 Jun; 69(6):1208.e5-8. PubMed ID: 17572221
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of magnetic resonance imaging-guided prostate biopsy in the supine position on the detection of significant prostate cancer in an inhomogeneous patient cohort.
    Engelhard K; Kühn R; Osten A; Bogner K; Dworak A; Lübke L; Schneider F
    Scand J Urol; 2016; 50(2):110-5. PubMed ID: 26539999
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gleason Score Determination with Transrectal Ultrasound-Magnetic Resonance Imaging Fusion Guided Prostate Biopsies--Are We Gaining in Accuracy?
    Lanz C; Cornud F; Beuvon F; Lefèvre A; Legmann P; Zerbib M; Delongchamps NB
    J Urol; 2016 Jan; 195(1):88-93. PubMed ID: 26165586
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical Outcome Following Low Suspicion Multiparametric Prostate Magnetic Resonance Imaging or Benign Magnetic Resonance Imaging Guided Biopsy to Detect Prostate Cancer.
    Boesen L; Nørgaard N; Løgager V; Thomsen HS
    J Urol; 2017 Aug; 198(2):310-315. PubMed ID: 28235549
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Multiparametric magnetic resonance imaging guided diagnostic biopsy detects significant prostate cancer and could reduce unnecessary biopsies and over detection: a prospective study.
    Thompson JE; Moses D; Shnier R; Brenner P; Delprado W; Ponsky L; Pulbrook M; Böhm M; Haynes AM; Hayen A; Stricker PD
    J Urol; 2014 Jul; 192(1):67-74. PubMed ID: 24518762
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The influence of prostate-specific antigen density on positive and negative predictive values of multiparametric magnetic resonance imaging to detect Gleason score 7-10 prostate cancer in a repeat biopsy setting.
    Hansen NL; Barrett T; Koo B; Doble A; Gnanapragasam V; Warren A; Kastner C; Bratt O
    BJU Int; 2017 May; 119(5):724-730. PubMed ID: 27488931
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Visually Estimated MRI Targeted Prostate Biopsy Could Improve the Detection of Significant Prostate Cancer in Patients with a PSA Level <10 ng/mL.
    Lee DH; Nam JK; Park SW; Lee SS; Han JY; Lee SD; Lee JW; Chung MK
    Yonsei Med J; 2016 May; 57(3):565-71. PubMed ID: 26996553
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Where Do Transrectal Ultrasound- and Magnetic Resonance Imaging-guided Biopsies Miss Significant Prostate Cancer?
    Boesen L; Nørgaard N; Løgager V; Balslev I; Thomsen HS
    Urology; 2017 Dec; 110():154-160. PubMed ID: 28866023
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Does transrectal ultrasound guided eight-core prostate biopsy improve cancer detection rates in patients with prostate-specific antigen levels of 4.1-10 ng/mL?
    Yamamoto S; Ito T; Aizawa T; Noda K; Umezu K; Ohtsuru N; Hata K
    Int J Urol; 2004 Jun; 11(6):386-91. PubMed ID: 15157207
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Safety and morbidity of first and repeat transrectal ultrasound guided prostate needle biopsies: results of a prospective European prostate cancer detection study.
    Djavan B; Waldert M; Zlotta A; Dobronski P; Seitz C; Remzi M; Borkowski A; Schulman C; Marberger M
    J Urol; 2001 Sep; 166(3):856-60. PubMed ID: 11490233
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Magnetic resonance imaging targeted biopsy in men with previously negative prostate biopsy results.
    Lee SH; Chung MS; Kim JH; Oh YT; Rha KH; Chung BH
    J Endourol; 2012 Jul; 26(7):787-91. PubMed ID: 22122555
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Direct comparison of targeted MRI-guided biopsy with systematic transrectal ultrasound-guided biopsy in patients with previous negative prostate biopsies.
    Kaufmann S; Kruck S; Kramer U; Gatidis S; Stenzl A; Roethke M; Scharpf M; Schilling D
    Urol Int; 2015; 94(3):319-25. PubMed ID: 25227711
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Patients with a history of elevated prostate-specific antigen levels and negative transrectal US-guided quadrant or sextant biopsy results: value of MR imaging.
    Beyersdorff D; Taupitz M; Winkelmann B; Fischer T; Lenk S; Loening SA; Hamm B
    Radiology; 2002 Sep; 224(3):701-6. PubMed ID: 12202702
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Multiparametric magnetic resonance imaging and ultrasound fusion biopsy detect prostate cancer in patients with prior negative transrectal ultrasound biopsies.
    Vourganti S; Rastinehad A; Yerram N; Nix J; Volkin D; Hoang A; Turkbey B; Gupta GN; Kruecker J; Linehan WM; Choyke PL; Wood BJ; Pinto PA
    J Urol; 2012 Dec; 188(6):2152-2157. PubMed ID: 23083875
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Endorectal magnetic resonance imaging and magnetic resonance spectroscopy to monitor the prostate for residual disease or local cancer recurrence after transrectal high-intensity focused ultrasound.
    Cirillo S; Petracchini M; D'Urso L; Dellamonica P; Illing R; Regge D; Muto G
    BJU Int; 2008 Aug; 102(4):452-8. PubMed ID: 18476973
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 55.